Home | RGCC Group

At RGCC Group, we envision a future where disease management is highly personalized, precise, and proactive — improving healthcare worldwide. Our team of scientists and medical experts conducts ongoing research and develops a range of reliable medical solutions, enabling patients and clinicians to make informed healthcare decisions.

The company was founded with a clear vision to redefine healthcare, especially cancer care, by merging precision medicine with innovative drug development. Its aim is to close the gap between cutting-edge molecular insights and targeted therapies, ensuring that breakthroughs in research swiftly translate into meaningful, individualized treatment options for patients. By uniting diagnostic excellence, therapeutic innovation, and a strong clinical network, RGCC Group is building a future of better-informed and personalized decisions for every patient’s medical care.

What sets RGCC Group apart is its fully integrated approach, uniting risk assessments for diseases, advanced diagnostics, drug discovery, and personalized therapies, all under one umbrella. With this model, RGCC Group bridges innovation and care through dynamic collaboration across its three main business divisions.

RGCC: Additional Advanced Diagnostic Tests

RGCC International

RGCC International specializes in cancer research and personalized therapies. Using innovative blood tests and biomarker analyses, RGCC develops tailored cancer diagnostics and treatments, recognizing that every patient is unique and responds individually to therapy.

Welmedis

At Welmedis, the focus is on cancer care research, with an emphasis on developing targeted therapeutics and driving drug discovery innovation. Using gene and protein expression data from the RGCC target identification platform, the team discovers novel targets for small-molecule therapeutics.

Biocentaur

Biocentaur has developed a range of highly reliable tests designed to empower individuals to make more informed decisions about their health. With expertise in molecular biology, they developed techniques to accurately diagnose diseases and improve patient outcomes.

Vision and Mission

In 2004, genetics pioneer Dr. Ioannis Papasotiriou founded RGCC with a deep commitment to personalized medicine. Guided by his steadfast belief in the power of each patient’s genetic makeup, he has consistently declined external funding to preserve his vision and ensure a science-driven approach to treating cancer and other chronic diseases.

Until today, RGCC's vision is to transform global healthcare by pioneering personalized, precise, and reliable medical solutions, redefining the way diseases, particularly cancer, are diagnosed, treated, and managed.

Our core competences

Integrated precision medicine: Liquid biopsies, Circulating Tumor Cell (CTC) analyses, tumor profiling

Genomics & molecular biology: Genetic mutations, epigenetics, and immune profiling

Therapeutic development: Drug screening, resistance testing, natural compound evaluation

Precision medicine R&D: Bridging lab insights with clinical application

Advanced therapies: Development of cutting-edge approaches for innovative and personalized treatment solutions

Quality: Upholding standards, following Good Manufacturing Practices (GMP) through in-house product development and validation, while rigorously verifying external solutions to ensure accuracy, reliability, and trust.

Clinical research & CRO services: Accelerating trial readiness and regulatory compliance across Europe

Personalized risk profiling: Tools like tests from Biocentaur that assess genetic predispositions, empowering preventive healthcare decisions.

Core values

Innovation: Continuously pushing the boundaries of science and medicine through groundbreaking research and advanced technology.

Personalization: Championing a patient-centered approach where therapies and diagnostics are tailored to individual needs and molecular profiles.

Collaboration: Fostering interdisciplinary teamwork across diagnostics, drug development, and clinical applications to deliver integrated healthcare solutions.

Curiosity: Being driven by a deep-seated desire to explore, question, and innovate across all areas of healthcare and science.

RGCC Group bridges the gap between research and personalized approaches

The Divisions of RGCC Group